Patents by Inventor Jinchen LV

Jinchen LV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230399325
    Abstract: Disclosed are salts of N-Cyclopentyl-5-(2-((5-((4-ethylpiperazin-1-yl) methyl) pyridin-2-yl) amino)-5-fluoropyrim-idin-4-yl)-4-methylthiazol-2-amine and polymorphs thereof, which are inhibitors of protein kinases, in particular cyclin-dependent kinase 4/6 (CDK4/6), and can be used to treat proliferative disorders, such as cancer, and other diseases related to protein kinase/CDK activity.
    Type: Application
    Filed: November 10, 2021
    Publication date: December 14, 2023
    Inventors: Shudong WANG, Hui WANG, Jinchen LV, Jun LIU
  • Patent number: 11566024
    Abstract: Disclosed are a tartrate of 3-(5-fluoro-4-(4-methyl-2-(methylamino)thiazol-5-yl) pyrimidin-2-ylamino)-benzenesulfonamide and a polymorph thereof, which are inhibitors of protein kinases, in particular cyclin-dependent kinase 9 (CDK9), and can be used to treat proliferative disorders, such as cancer, and other diseases related to protein kinase/CDK activity.
    Type: Grant
    Filed: May 29, 2019
    Date of Patent: January 31, 2023
    Inventors: Shudong Wang, Hui Wang, Liqun Jiang, Jinchen Lv, Wenjian Ju
  • Publication number: 20210139474
    Abstract: Disclosed are a tartrate of 3-(5-fluoro-4-(4-methyl-2-(methylamino)thiazol-5-yl) pyrimidin-2-ylamino)-benzenesulfonamide and a polymorph thereof, which are inhibitors of protein kinases, in particular cyclin-dependent kinase 9 (CDK9), and can be used to treat proliferative disorders, such as cancer, and other diseases related to protein kinase/CDK activity.
    Type: Application
    Filed: May 29, 2019
    Publication date: May 13, 2021
    Inventors: Shudong WANG, Hui WANG, Liqun JIANG, Jinchen LV, Wenjian JU